Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SUBSTITUTED HETEROCYCLIC DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME
Document Type and Number:
WIPO Patent Application WO/2023/121238
Kind Code:
A1
Abstract:
The present invention relates to a substituted heterocyclic derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition for preventing or treating cancer comprising same as an active ingredient.

Inventors:
KIM JUN-KYUM (KR)
CHOI JIA (KR)
KIM EUN-JUNG (KR)
PARK CHEOL-KYU (KR)
HAM SEOK WON (KR)
PARK MIN GI (KR)
JEONG HYEON JU (KR)
KIM SUNG JIN (KR)
MIN KYUNGIM (KR)
PARK JONG MIN (KR)
CHIN JUNGWOOK (KR)
CHO SUNG JIN (KR)
KIM JINA (KR)
JUNG KYUNG JIN (KR)
KIM NAYEON (KR)
KIM SUHUI (KR)
KWON SUGYEONG (KR)
LEE SU-JEONG (KR)
JEONG MINSEON (KR)
AN HONGCHAN (KR)
PARK JEONG-EUN (KR)
KIM DONG-HYUN (KR)
LIM JI-YOUN (KR)
MIN JU-SIK (KR)
HWANG JI SUN (KR)
CHOI HYO-JUNG (KR)
HWANG HAYOUNG (KR)
KWON OH-BIN (KR)
LEE SUNGWOO (KR)
KIM SANG BUM (KR)
Application Number:
PCT/KR2022/020866
Publication Date:
June 29, 2023
Filing Date:
December 20, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEDIFIC INC (KR)
DAEGU GYEONGBUK MEDICAL INNOVATION FOUND (KR)
International Classes:
C07D403/04; A61K31/403; A61K31/4155; A61K31/4439; A61K31/506; C07D401/04; C07D405/04; C07D409/04; C07D413/04; C07D417/04
Domestic Patent References:
WO2016196664A12016-12-08
WO2020131573A12020-06-25
WO2014041125A12014-03-20
WO2006011024A22006-02-02
Foreign References:
KR20200061813A2020-06-03
Attorney, Agent or Firm:
PLUS INTERNATIONAL IP LAW FIRM (KR)
Download PDF: